Cargando…
Improving use of proton pump inhibitors with dual antiplatelet therapy in patients admitted with acute coronary syndrome
Acute coronary syndrome (ACS) is one of the leading causes of morbidity and mortality with a major impact on healthcare resources and expenditure. Dual antiplatelet therapy (DAPT) is recommended for the treatment of ACS. DAPT is associated with an increased risk of gastrointestinal (GI) bleeding, wh...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BMJ Publishing Group
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9791429/ https://www.ncbi.nlm.nih.gov/pubmed/36564103 http://dx.doi.org/10.1136/bmjoq-2022-001956 |